Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-W031727 |
Brand: | MCE |
CAS: | 118-42-3 |
MDL | MFCD00242707 |
---|---|
Molecular Weight | 335.87 |
Molecular Formula | C18H26ClN3O |
SMILES | ClC1=CC=C2C(NC(CCCN(CCO)CC)C)=CC=NC2=C1 |
Hydroxychloroquine is a synthetic antimalarial agent which can also inhibit Toll-like receptor 7/9 ( TLR7/9 ) signaling. Hydroxychloroquine is efficiently inhibits SARS-CoV-2 infection in vitro [1] [2] [3] .
Plasmodium
|
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT03229746 | Assiut University |
Immune Thrombocytopenia
|
August 1, 2017 | Phase 4 |
NCT04325893 | University Hospital, Angers |
Coronavirus
|
April 1, 2020 | Phase 3 |
NCT04447534 | Tanta University |
COVID
|
June 23, 2020 | Phase 3 |
NCT04554979 | Cairo University |
Covid19|Diarrhea
|
June 1, 2020 | |
NCT04363203 | Salomeh Keyhani MD|San Francisco VA Health Care System |
SARS-CoV-2|COVID-19
|
April 30, 2020 | Phase 3 |
NCT02026232 | Washington University School of Medicine |
Type 2 Diabetes Mellitus
|
March 2012 | Not Applicable |
NCT04593758 | Cornerstone Pharmaceuticals |
Sarcoma, Clear Cell
|
September 1, 2021 | Phase 1|Phase 2 |
NCT03598595 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Recurrent Osteosarcoma|Refractory Osteosarcoma
|
January 28, 2019 | Phase 1|Phase 2 |
NCT04352933 | Cambridge University Hospitals NHS Foundation Trust |
COVID-19
|
May 11, 2020 | Phase 3 |
NCT04355052 | Sheba Medical Center |
COVID - 19
|
April 11, 2020 | Phase 3 |
NCT04323631 | Rambam Health Care Campus|Rabin Medical Center |
COVID-19
|
April 30, 2020 | Early Phase 1 |
NCT01148043 | Maasstad Hospital |
Osteoarthritis
|
July 2010 | Phase 3 |
NCT04605588 | Rutgers, The State University of New Jersey|SynaVir |
SARS-CoV Infection|Covid19
|
December 2, 2020 | Phase 2 |
NCT02257424 | Abramson Cancer Center of the University of Pennsylvania |
Advanced BRAF Mutant Melanoma
|
October 2014 | Phase 1|Phase 2 |
NCT04911816 | West Virginia University |
Adenocarcinoma of the Pancreas
|
July 16, 2021 | Phase 1|Phase 2 |
NCT04366089 | Roberto Poscia MD, PhD|Azienda Policlinico Umberto I |
COVID|SARS-CoV 2|Pneumonia, Viral|Coronavirus Infection
|
March 26, 2020 | Phase 2 |
NCT04411433 | Ministry of Health, Turkey|Hacettepe University, Faculty of Medicine|Prof. Dr. Cemil Tasc?oglu Education and Research Hospital Organization|Umraniye Education and Research Hospital|SB Istanbul Education and Research Hospital|Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey|Tepecik Training and Research Hospital|Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine|Ankara University|Ankara City Hospital Bilkent|Ankara Training and Research Hospital|Ege University Hospital (Application and Research Center)|Kocaeli Derince Education and Research Hospital|Istanbul University|Kayseri City Hospital |
Sars-CoV2|COVID-19
|
May 8, 2020 | Phase 3 |
NCT04389320 | Assiut University |
Rheumatoid Arthritis
|
March 15, 2020 | |
NCT02475915 | South East Asia Research Collaboration with Hawaii|The Thai Red Cross AIDS Research Centre|Cooper Human Systems |
Acute HIV Infection
|
January 2015 | Phase 1|Phase 2 |
NCT02648464 | Helsinki University Central Hospital|Finnish Foundation for Cardiovascular Research|Orion Corporation, Orion Pharma|Aarne Koskelo Foundation|Finnish Cultural Foundation |
Myocardial Infarction|Acute Coronary Syndrome|Inflammation|Hydroxychloroquine|Antirheumatic Agents|Cardiovascular Diseases
|
February 1, 2016 | Phase 4 |
NCT00486603 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) |
Brain and Central Nervous System Tumors
|
October 29, 2007 | Phase 1|Phase 2 |
NCT04361461 | Apsen Farmaceutica S.A.|Federal University of São Paulo |
Coronavirus Infections|SARS-CoV 2|SARS (Severe Acute Respiratory Syndrome)|Pulmonary Disease
|
April 30, 2020 | Phase 3 |
NCT04459702 | ProgenaBiome|Big Corona Ltd. |
COVID|COVID-19|Corona Virus Infection|Coronavirus Infection|Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere|Coronavirus-19|SARS-CoV 2|SARS Pneumonia
|
July 2020 | Phase 2 |
NCT04372017 | Sanford Health |
COVID-19|SARS-CoV 2
|
May 14, 2020 | Phase 3 |
NCT02644499 | Jawaharlal Institute of Postgraduate Medical Education & Research |
Rheumatoid Arthritis
|
December 31, 2015 | Phase 4 |
NCT02942381 | Peking University First Hospital |
IgA Patients|Hydroxychloroquine
|
September 13, 2016 | Phase 2 |
NCT01760421 | National Taiwan University Hospital |
Hashimoto Thyroiditis
|
October 2011 | Not Applicable |
NCT04351919 | Abderrahmane Mami Hospital|Eshmoun Clinical Research Center|Dacima Consulting |
Patients With COVID19
|
May 5, 2020 | Phase 4 |
NCT05024006 | University of the Philippines |
Covid19
|
April 23, 2020 | Not Applicable |
NCT00786682 | University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey |
Prostate Cancer
|
December 2008 | Phase 2 |
NCT02414776 | Western Regional Medical Center |
Estrogen Receptor Positive Breast Cancer
|
July 2014 | Phase 1 |
NCT03687905 | Tanta University |
Proliferative Nephritis|Chloroquine Retinopathy
|
September 18, 2018 | |
NCT04380818 | Grupo de Investigación Clínica en Oncología Radioterapia|Hospital Universitario Madrid Sanchinarro|Hospital del Mar|Hospital Universitari Sant Joan de Reus |
Pneumonia, Viral
|
June 5, 2020 | Not Applicable |
NCT05083780 | Changhoon Yoo|Oncocross Co. Ltd.|CytoGen, Inc.|Asan Medical Center |
Pancreatic Cancer
|
November 30, 2021 | Phase 1 |
NCT03929211 | Wake Forest University Health Sciences|National Cancer Institute (NCI) |
Myelodysplastic Syndromes|Progressive Disease
|
May 2021 | Phase 1|Phase 2 |
NCT04351516 | University Hospital Tuebingen |
SARS-CoV 2|COVID-19
|
April 21, 2020 | Phase 2|Phase 3 |
NCT04316169 | Medical College of Wisconsin |
Solid Tumor|Advanced Breast Cancer
|
October 21, 2021 | Phase 1 |
NCT00765765 | University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey |
Breast Cancer
|
February 2009 | Phase 1|Phase 2 |
NCT03774472 | M.D. Anderson Cancer Center |
Anatomic Stage I Breast Cancer AJCC v8|Anatomic Stage IA Breast Cancer AJCC v8|Anatomic Stage IB Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage IIA Breast Cancer AJCC v8|Anatomic Stage IIB Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Prognostic Stage I Breast Cancer AJCC v8|Prognostic Stage IA Breast Cancer AJCC v8|Prognostic Stage IB Breast Cancer AJCC v8|Prognostic Stage IIA Breast Cancer AJCC v8|Prognostic Stage IIB Breast Cancer AJCC v8|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8
|
August 20, 2018 | Phase 1|Phase 2 |
NCT04384458 | Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara |
Coronavirus Infections
|
July 20, 2020 | Not Applicable |
NCT04715295 | Yaounde Central Hospital |
COVID-19
|
October 5, 2020 | Phase 4 |
NCT04347889 | Stony Brook University |
Covid-19
|
April 20, 2020 | Phase 2 |
NCT04345692 | Queen´s Medical Center |
COVID-19
|
March 26, 2020 | Phase 3 |
NCT04365582 | Groupe Hospitalier Paris Saint Joseph |
COVID
|
May 7, 2020 | Phase 3 |
NCT04523857 | Abramson Cancer Center of the University of Pennsylvania |
Breast Cancer
|
November 1, 2021 | Phase 2 |
NCT01551069 | Sanofi |
Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
|
March 2012 | Phase 3 |
NCT04328285 | Centre Hospitalier Universitaire de Saint Etienne|Institut Pasteur |
COVID-19
|
April 14, 2020 | Phase 3 |
NCT03122431 | University of Sao Paulo General Hospital|Fundação de Amparo à Pesquisa do Estado de São Paulo |
Systemic Lupus Erythematosus (SLE)|Juvenile SLE|Cutaneous Lupus
|
June 5, 2017 | Phase 4 |
NCT04315896 | National Institute of Respiratory Diseases, Mexico |
COVID-19|Severe Acute Respiratory Syndrome
|
April 14, 2020 | Phase 3 |
NCT04163107 | Norwegian University of Science and Technology|St. Olavs Hospital|Oslo University Hospital |
Multiple Myeloma
|
January 7, 2020 | Phase 1 |
NCT04405921 | Centre Hôpital Universitaire Farhat Hached |
SARS-CoV-2 Pneumonia|COVID-19
|
July 2020 | Phase 3 |
NCT04339816 | Frantisek Duska, MD, PhD|Masaryk Hospital Usti nad Labem|University Hospital Pilsen|The Faculty Hospital Na Bulovce|St. Anne´s University Hospital Brno, Czech Republic|University Hospital, Motol|General University Hospital, Prague|University Hospital Olomouc|Charles University, Czech Republic |
COVID-19|Respiratory Failure
|
May 13, 2020 | Phase 3 |
NCT01040195 | Sanjay Gandhi Postgraduate Institute of Medical Sciences |
Seronegative Spondyloarthropathies
|
June 2009 | Phase 3 |
NCT04652648 | Bryn Mawr Hospital|Sharpe-Strumia Research Foundation|Bryn Mawr Hospital Foundation|Cotswold Foundation |
Covid19|Hydroxychloroquine|Coronavirus Infection|Transmission|Prophylaxis
|
May 27, 2020 | Phase 4 |
NCT04937907 | Shanghai Children´s Hospital |
Alport Syndrome, X-Linked
|
September 8, 2021 | Phase 2 |
NCT04364815 | University of the Philippines |
COVID-19
|
December 2020 | Phase 3 |
NCT00726596 | Rutgers, The State University of New Jersey|Rutgers Cancer Institute of New Jersey|National Cancer Institute (NCI) |
Prostate Cancer
|
August 2008 | Phase 2 |
NCT04597775 | Regional Center for Disease Control and Prevention, Jordan|Farhat Hached Hospital, Tunisia|Fattouma Bourguiba, Tunisia |
SARS-CoV Infection
|
October 27, 2020 | Phase 2|Phase 3 |
NCT01709578 | Sanofi|Regeneron Pharmaceuticals |
Rheumatoid Arthritis
|
October 2012 | Phase 3 |
NCT04334148 | Adrian Hernandez|Patient-Centered Outcomes Research Institute|Duke University |
COVID-19
|
April 22, 2020 | Phase 3 |
NCT04360759 | University of Cape Town |
Covid-19|HIV
|
May 1, 2020 | Phase 3 |
NCT04381936 | University of Oxford|UK Research and Innovation|National Institute for Health Research, United Kingdom|Wellcome|Bill and Melinda Gates Foundation|Department for International Development, United Kingdom|Health Data Research UK|Medical Research Council Population Health Research Unit|NIHR Clinical Trials Unit Support Funding|NIHR Health Protection Research Unit in Emerging and Zoonotic Infections |
Severe Acute Respiratory Syndrome
|
March 19, 2020 | Phase 2|Phase 3 |
NCT04389359 | Cambridge University Hospitals NHS Foundation Trust|University of Cambridge |
COVID-19
|
September 2020 | Phase 2|Phase 3 |
NCT04145297 | University of Utah|BioMed Valley Discoveries, Inc |
Gastrointestinal Neoplasms
|
March 17, 2020 | Phase 1 |
NCT01978184 | Nathan Bahary, MD|University of Pittsburgh |
Pancreatic Cancer
|
November 2013 | Phase 2 |
NCT02466581 | Karolinska Institutet |
Rheumatoid Arthritis
|
February 3, 2015 | Phase 4 |
NCT04788355 | Universidade do Vale do Sapucai|Pfizer|Apsen Farmaceutica S.A.|Dermadia|Methodos Laboratory|Biofarma |
Complication
|
July 1, 2020 | Phase 3 |
NCT04005781 | Universitaire Ziekenhuizen KU Leuven |
Obesity
|
October 1, 2019 | Phase 4 |
NCT03180190 | Assiut University |
Autoimmune Diseases
|
June 28, 2017 | |
NCT05221320 | BioMed Valley Discoveries, Inc |
Tumor, Solid|Gastrointestinal Cancer
|
May 26, 2022 | Phase 2 |
NCT04420247 | Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva |
COVID|COVID-19|SARS-CoV 2|Coronavirus|Corona Virus Infection
|
April 16, 2020 | Phase 3 |
NCT01132118 | Brigham and Women´s Hospital|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
Rheumatoid Arthritis|Insulin Resistance
|
June 2010 | Phase 3 |
NCT04342169 | University of Utah |
Coronavirus Infection|Coronavirus|Infectious Disease
|
April 4, 2020 | Phase 2 |
NCT04334928 | Plan Nacional sobre el Sida (PNS)|Effice Servicios Para la Investigacion S.L. |
Coronavirus Infection
|
April 15, 2020 | Phase 3 |
NCT04372082 | University Hospital, Lille|I-site University Lille North Europe |
Sars-CoV2
|
May 2020 | Phase 3 |
NCT01144169 | University of Pittsburgh|National Institutes of Health (NIH) |
Renal Cell Carcinoma
|
October 2010 | Phase 1 |
NCT04331834 | Barcelona Institute for Global Health|Hospital Clinic of Barcelona|Laboratorios Rubió|Fundació Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau|Hospital Plató|Hospital de Granollers |
COVID-19
|
April 3, 2020 | Phase 3 |
NCT00809237 | National University Hospital, Singapore|Massachusetts General Hospital|AstraZeneca |
Non-small Cell Lung Cancer
|
November 2008 | Phase 1|Phase 2 |
NCT01783106 | Royal Liverpool University Hospital|National Association for Colitis and Crohn´s Disease|National Institute for Health Research, United Kingdom |
Crohn´s Disease
|
February 1, 2014 | Phase 2 |
NCT05113004 | Assistance Publique - Hôpitaux de Paris |
Primary Sjögren´s Syndrome (pSS)
|
January 20, 2022 | Phase 2 |
NCT05016297 | Peking Union Medical College Hospital|Eli Lilly and Company |
Sjogren´s Syndrome
|
July 14, 2022 | Phase 2 |
NCT01326533 | University of Pittsburgh|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Pre-diabetes
|
March 2011 | Phase 4 |
NCT04358068 | National Institute of Allergy and Infectious Diseases (NIAID)|Teva Pharmaceutical Industries, Ltd. |
COVID-19|SARS-CoV 2
|
May 13, 2020 | Phase 2 |
NCT05576896 | Northwestern University|National Cancer Institute (NCI) |
Stage IV Colorectal Cancer Positive for BRAF V600E Mutation|Colorectal Cancer|Colorectal Cancer Stage IV
|
October 10, 2022 | Phase 2 |
NCT02057250 | Sanofi|Regeneron Pharmaceuticals |
RA
|
March 2014 | Phase 3 |
NCT04344457 | Perseverance Research Center, LLC|Athena Medical Group |
COVID-19
|
April 16, 2020 | Phase 1|Phase 2 |
NCT04341493 | Hugo Mendieta Zeron|Materno-Perinatal Hospital of the State of Mexico |
Coronavirus Infection
|
April 6, 2020 | Phase 4 |
NCT05013463 | University of Calgary |
Multiple Sclerosis, Secondary Progressive
|
October 1, 2021 | Phase 2 |
NCT04370782 | St. Francis Hospital, New York |
COVID-19
|
April 28, 2020 | Phase 4 |
NCT04350450 | Montefiore Medical Center |
COVID|Coronavirus|COVID-19
|
April 2020 | Phase 2 |
NCT04120883 | University of Michigan|Cures Within Reach |
Retinitis Pigmentosa
|
February 25, 2020 | Phase 1|Phase 2 |
NCT04341727 | Washington University School of Medicine |
Coronavirus Infection
|
April 4, 2020 | Phase 3 |
NCT02351752 | LLiu|Peking University First Hospital |
Primary IgA Nephropathy
|
January 2015 | Phase 4 |
NCT01687179 | Brigham and Women´s Hospital|National Heart, Lung, and Blood Institute (NHLBI) |
Lymphangioleiomyomatosis
|
September 2012 | Phase 1 |
NCT01067417 | Medical Research Council|Wellcome Trust |
HIV Infections
|
June 2008 | Phase 2 |
NCT01023737 | Sukeshi Patel|Merck Sharp & Dohme LLC|The University of Texas Health Science Center at San Antonio |
Malignant Solid Tumour
|
November 2009 | Phase 1 |
NCT05311813 | Beni-Suef University |
COVID-19 Pandemic
|
June 1, 2021 | Not Applicable |
NCT04381988 | Memorial Sloan Kettering Cancer Center |
COVID-19|Cancer
|
May 7, 2020 | Phase 2 |
NCT04397328 | Lawson Health Research Institute |
COVID-19
|
May 19, 2020 | Phase 3 |
NCT04007562 | Assistance Publique - Hôpitaux de Paris |
LIPIN1 Deficiency
|
July 2019 | |
NCT04461353 | Pulmoquine Therapeutics, Inc|Rockefeller University |
Severe Acute Respiratory Syndrome Coronavirus 2
|
June 25, 2020 | Phase 1 |
NCT02079077 | University of Manitoba|University of Nairobi |
HIV
|
April 2014 | Not Applicable |
NCT04334382 | Intermountain Health Care, Inc.|University of Utah|Utah Department of Health |
COVID-19
|
April 2, 2020 | Phase 3 |
NCT03165136 | University Hospital, Brest |
Recurrent Miscarriage|First Trimester Abortion
|
December 4, 2017 | Phase 3 |
NCT01073852 | Vanderbilt University |
Chronic Urticaria
|
June 2011 | Not Applicable |
NCT04392128 | Institut de cancérologie Strasbourg Europe |
COVID19|Hematologic Malignancy
|
September 2, 2020 | Phase 2 |
NCT02874287 | First Affiliated Hospital Xi´an Jiaotong University |
Coronary Artery Disease
|
October 8, 2017 | Phase 4 |
NCT04668469 | Benha University |
Covid19
|
June 8, 2020 | Not Applicable |
NCT04348474 | Azidus Brasil |
Covid-19
|
April 20, 2020 | Early Phase 1 |
NCT03030118 | Milton S. Hershey Medical Center|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
Systemic Lupus Erythematosus
|
December 28, 2017 | Phase 2 |
NCT00405275 | US Department of Veterans Affairs|Canadian Institutes of Health Research (CIHR)|Rheumatoid Arthritis Investigational Network (RAIN)|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|VA Office of Research and Development |
Rheumatoid Arthritis
|
July 2007 | Not Applicable |
NCT04342221 | University Hospital Tuebingen|Robert Bosch Medical Center|Universitätsklinikum Hamburg-Eppendorf|Bernhard Nocht Institute for Tropical Medicine |
COVID-19, Hydroxychloroquine Sulfate
|
March 29, 2020 | Phase 3 |
NCT04384380 | Taoyuan General Hospital|Center for Drug Evaluation, Taiwan|Centers for Disease Control, Taiwan|Taiwan Food and Drug Administration|National Health Research Institutes, Taiwan |
Coronavirus Infection
|
April 1, 2020 | Not Applicable |
NCT01784523 | Hospital for Special Surgery, New York|AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking|The New York Community Trust |
Antiphospholipid Syndrome
|
February 2013 | Phase 3 |
NCT05247554 | Assistance Publique - Hôpitaux de Paris |
Pulmonary Sarcoidosis
|
March 1, 2022 | Phase 3 |
NCT00176982 | Hordinsky, Maria K., MD|University of Minnesota |
Alopecia Areata
|
April 2002 | Phase 4 |
NCT01601028 | Seoul National University Hospital |
Autoimmune Diseases|Sjogren´s Syndrome|Dry Eye
|
July 2011 | Phase 3 |
NCT03449758 | Sanofi|Regeneron Pharmaceuticals |
Rheumatoid Arthritis
|
March 5, 2018 | Phase 4 |
NCT02765594 | Peking Union Medical College Hospital |
Primary IgA Nephropathy
|
June 2016 | Phase 4 |
NCT01828476 | Rutgers, The State University of New Jersey|Rutgers Cancer Institute of New Jersey|National Cancer Institute (NCI)|AbbVie |
Prostate Cancer
|
June 2013 | Phase 2 |
NCT01649947 | Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey |
Non-small Cell Lung Cancer|Advanced Non-small Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer
|
December 23, 2011 | Phase 2 |
NCT04329572 | Azidus Brasil |
COVID-19
|
April 23, 2020 | Early Phase 1 |
NCT01768572 | Sanofi|Regeneron Pharmaceuticals |
Rheumatoid Arthritis
|
March 2013 | Phase 3 |
NCT03283566 | The Cleveland Clinic|Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)|Stanford University |
Chronic Pancreatitis|Insulin Dependent Diabetes
|
October 3, 2017 | Phase 2 |
NCT04410562 | Barcelona Institute for Global Health|Hospital Clinic of Barcelona|Fundació Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau|University Hospital of Torrejon|Fundación de investigación HM|Hospital Sant Joan de Deu|Hospital del Mar|Hospital Universitario Infanta Leonor|Hospital Universitario Fundación Alcorcón|Hospital General de Segovia|Institut Català de la Salut |
Pregnancy Related|COVID|Covid-19
|
May 13, 2020 | Phase 3 |
NCT04359316 | Shahid Beheshti University of Medical Sciences |
COVID-19
|
April 20, 2020 | Phase 4 |
NCT04359615 | Shahid Beheshti University of Medical Sciences |
COVID-19
|
April 20, 2020 | Phase 4 |
NCT04918524 | Qilu Hospital of Shandong University |
Connective Tissue Diseases|Pregnancy Related
|
September 11, 2018 | |
NCT05119140 | Icahn School of Medicine at Mount Sinai|Crohn´s and Colitis Foundation |
Ulcerative Colitis (Disorder)
|
June 10, 2022 | Phase 1|Phase 2 |
NCT04328961 | University of Washington|Bill and Melinda Gates Foundation |
COVID-19|Corona Virus Infection|SARS (Severe Acute Respiratory Syndrome)|SARS-CoV-2
|
March 31, 2020 | Phase 2|Phase 3 |
NCT01379573 | NYU Langone Health |
Congenital Heart Block|Neonatal Lupus|Autoantibody-Associated Heart Block
|
January 1, 2011 | Phase 2 |
NCT04333654 | Sanofi |
Coronavirus Infection
|
April 12, 2020 | Phase 1 |
NCT01946880 | National Institute of Allergy and Infectious Diseases (NIAID)|Autoimmunity Centers of Excellence|Rho Federal Systems Division, Inc. |
Systemic Lupus Erythematosus|SLE
|
November 20, 2013 | Phase 2 |
NCT04365231 | Hospital St. Joseph, Marseille, France |
COVID19
|
April 1, 2020 | Phase 3 |
NCT04334512 | ProgenaBiome|DSCS CRO |
COVID-19|Corona Virus Infection|Coronavirus-19|Sars-CoV2
|
June 22, 2020 | Phase 2 |
NCT04351191 | Government of Punjab, Specialized Healthcare and Medical Education Department|Mayo Hospital Lahore|Services Hospital, Lahore|Pakistan Kidney and Liver Institute |
Sars-CoV2|Symptomatic Condition|Covid-19
|
April 15, 2020 | Phase 4 |
NCT04354870 | NYU Langone Health |
COVID-19
|
April 3, 2020 | Phase 2 |
NCT02379650 | University of Utah|Intermountain Health Care, Inc. |
Recurrent Pregnancy Loss|Miscarriage
|
July 2016 | Phase 2 |
NCT01602588 | University College, London|Cancer Research UK |
Glioblastoma
|
May 2013 | Phase 2 |
NCT02374021 | Brigham and Women´s Hospital|Columbia University |
Arthritis, Rheumatoid
|
July 2016 | Phase 4 |
NCT04712279 | Corpometria Institute |
Covid19
|
January 25, 2021 | Phase 2|Phase 3 |
NCT05126147 | National Taiwan University Hospital |
Graves Ophthalmopathy
|
December 1, 2021 | Phase 4 |
NCT04691505 | Brigham and Women´s Hospital|National Institute on Aging (NIA)|Rutgers University|Johns Hopkins University |
Rheumatoid Arthritis
|
December 23, 2020 | |
NCT04466280 | Baqiyatallah Medical Sciences University |
COVID-19
|
August 12, 2020 | Not Applicable |
NCT04344444 | LCMC Health |
COVID-19
|
April 13, 2020 | Phase 3 |
NCT04353336 | Tanta University |
COVID-19|Coronavirus Infection
|
March 23, 2020 | Phase 2|Phase 3 |
NCT03825289 | University of Utah|Novartis Pharmaceuticals |
Metastatic Pancreatic Carcinoma|Stage II Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer|Unresectable Pancreatic Carcinoma
|
January 18, 2019 | Phase 1 |
NCT04964583 | Coordinación de Investigación en Salud, Mexico|Ultra Laboratorios SA. de CV. |
Covid19
|
January 20, 2021 | Phase 2|Phase 3 |
NCT04363450 | Louisiana State University Health Sciences Center in New Orleans|Lafayette General Health|University of Louisiana at Lafayette |
COVID-19|Corona Virus Infection|Wuhan Coronavirus|Prophylaxis|Healthcare Worker|Sars-CoV2|Hydroxychloroquine
|
April 27, 2020 | Phase 3 |
NCT04438837 | Rambam Health Care Campus |
Coronavirus Disease 2019 (COVID-19)|Post-Exposure Prophylaxis
|
July 2020 | Not Applicable |
NCT04330144 | Gangnam Severance Hospital |
Contact Person From COVID-19 Confirmed Patient
|
April 1, 2020 | Phase 3 |
NCT04464759 | Ravi Amaravadi, MD|Bristol-Myers Squibb|Abramson Cancer Center of the University of Pennsylvania |
Melanoma
|
October 21, 2020 | Phase 1|Phase 2 |
NCT04338698 | Shehnoor Azhar|University of Health Sciences Lahore |
COVID 19
|
April 22, 2020 | Phase 3 |
NCT04400019 | University of Malaga|Instituto de Investigacion Biomedica de Malaga|Carlos III Health Institute |
Sars-CoV2|Coronavirus Infection|Prevention & Control|Nursing Home|Hydroxychloroquine
|
September 2020 | Phase 2|Phase 3 |
NCT04343768 | Shahid Beheshti University of Medical Sciences |
COVID-19
|
April 9, 2020 | Phase 2 |
NCT01689987 | OHSU Knight Cancer Institute|National Cancer Institute (NCI) |
Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma
|
September 2012 | Phase 1 |
NCT01232660 | St Stephens Aids Trust |
HIV Infection
|
October 2010 | Phase 1 |
NCT00813423 | National Cancer Institute (NCI) |
Adult Solid Neoplasm
|
January 27, 2010 | Phase 1 |
NCT04392973 | King Abdullah International Medical Research Center |
COVID19
|
May 21, 2020 | Not Applicable |
NCT04340349 | Instituto Nacional de Rehabilitacion |
Hydroxychloroquine|Antimalarials|Enzyme Inhibitors|Antirheumatic Agents
|
February 1, 2021 | Early Phase 1 |
NCT00311883 | Vanderbilt University |
Cystic Fibrosis
|
March 2006 | Phase 1 |
NCT01941095 | Hoffmann-La Roche |
Rheumatoid Arthritis
|
November 20, 2013 | Phase 3 |
NCT04022421 | Assiut University |
Behcet´s Syndrome, Vascular Type
|
October 1, 2018 | Not Applicable |
NCT05051137 | Karolinska Institutet|Harvard Medical School (HMS and HSDM) |
Rheumatoid Arthritis
|
January 12, 2006 | |
NCT00714181 | Abramson Cancer Center of the University of Pennsylvania|National Cancer Institute (NCI) |
Unspecified Adult Solid Tumor, Protocol Specific
|
June 2008 | Phase 1 |
NCT03085940 | Indonesia University |
Rheumatoid Arthritis
|
January 20, 2017 | Not Applicable |
NCT01266057 | M.D. Anderson Cancer Center |
Advanced Cancers
|
April 28, 2011 | Phase 1 |
NCT01510119 | Abramson Cancer Center of the University of Pennsylvania|University of Pittsburgh|Rutgers Cancer Institute of New Jersey |
Metastatic Clear Cell Renal Cell Carcinoma
|
September 2011 | Phase 1|Phase 2 |
NCT04527549 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group |
Clinical Stage IV Cutaneous Melanoma AJCC v8|Locally Advanced Melanoma|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Unresectable Melanoma
|
October 23, 2020 | Phase 2 |
NCT03081702 | University Health Network, Toronto |
Platinum-resistant Epithelial Ovarian Cancer
|
July 25, 2017 | Phase 1|Phase 2 |
NCT01128296 | Amer Zureikat|National Institutes of Health (NIH)|University of Pittsburgh |
Pancreatic Cancer
|
October 2010 | Phase 1|Phase 2 |
NCT04624269 | Shanghai First Maternity and Infant Hospital|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Shanghai Jiao Tong University Affiliated Sixth People´s Hospital|Fudan University|Zhejiang Provincial People´s Hospital|Zhejiang Provincial Tongde Hospital |
Antiphospholipid Syndrome|Recurrent Miscarriage
|
December 1, 2020 | Phase 4 |
NCT04132505 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Metastatic Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8
|
October 22, 2019 | Phase 1 |
NCT04787991 | Parker Institute for Cancer Immunotherapy|Bristol-Myers Squibb|Cancer Research Institute, New York City|PsiOxus Therapeutics Ltd |
Metastatic Pancreatic Adenocarcinoma
|
August 9, 2021 | Phase 1 |
NCT02126683 | National Taiwan University Hospital |
Hashimoto´s Thyroiditis
|
April 2014 | Not Applicable |
NCT04335084 | ProgenaBiome|DSCS CRO |
COVID-19|Coronavirus Infection|Sars-CoV2|Corona Virus Infection|COVID|Coronavirus|Coronavirus-19|Coronavirus 19
|
June 22, 2020 | Phase 2 |
NCT04329611 | Dr. Michael Hill|Alberta Health services|University of Alberta|University of Calgary|Calgary Health Trust|Alberta Innovates Health Solutions|Government of Alberta |
COVID-19
|
April 13, 2020 | Phase 3 |
NCT01506973 | Abramson Cancer Center of the University of Pennsylvania |
Advanced Adenocarcinoma|Metastatic Adenocarcinoma
|
December 2011 | Phase 1|Phase 2 |
NCT04394442 | Samah Lutfy|Zagazig University |
COVID-19
|
March 21, 2020 | Phase 2 |
NCT04363866 | Oregon Health and Science University|OHSU Knight Cancer Institute |
COVID-19|SARS-CoV-2
|
August 2020 | Phase 2 |
NCT04328272 | Prof. Dr. Umar Farooq|Ayub Medical College, Abbottabad |
COVID19
|
March 28, 2020 | Phase 3 |
NCT04379492 | Memorial Sloan Kettering Cancer Center |
COVID-19|COVID19|Sars-CoV2|SARS-Cov-2
|
May 5, 2020 | Phase 2 |
NCT04669197 | HonorHealth Research Institute |
Untreated Resectable Pancreatic Adenocarcinoma|Borderline Resectable Pancreatic Adenocarcinoma|Locally Advanced Pancreatic Adenocarcinoma
|
December 1, 2020 | Phase 2 |
NCT04342156 | Tan Tock Seng Hospital|National Center for Infectious Diseases|Singapore Clinical Research Institute|Singapore Eye Research Institute|Saw Swee Hock School of Public Health|Duke-NUS Graduate Medical School|Netherlands: Ministry of Health, Welfare and Sports |
Coronavirus Infection|Hydroxychloroquine Adverse Reaction
|
April 2020 | Phase 3 |
NCT04524702 | Emory University|National Cancer Institute (NCI) |
Advanced Pancreatic Adenocarcinoma|Metastatic Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8
|
September 14, 2020 | Phase 2 |
NCT04011410 | Andrew C. James, MD|University of Kentucky |
Prostate Cancer Recurrent
|
December 3, 2019 | Phase 2 |
NCT05084872 | University Hospital, Toulouse |
Mastocytosis
|
October 2021 | Phase 2|Phase 3 |
NCT04374942 | Megan Landes|University Health Network, Toronto |
Pre-Exposure Prophylaxis|Coronavirus|SARS-CoV 2
|
April 30, 2020 | Phase 3 |
NCT04376814 | Baqiyatallah Medical Sciences University |
COVID-19|Favipiravir|Kaletra|Hydroxychloroquine|Lopinavir+Ritonavir
|
March 29, 2020 | Not Applicable |
NCT03636152 | VA Office of Research and Development |
Chronic Kidney Disease|Cardiovascular Disease|Inflammation|Atherosclerosis|Aortic Stiffness
|
December 14, 2018 | Phase 2 |
NCT03344172 | Nathan Bahary, MD|Pfizer|National Cancer Institute (NCI)|University of Pittsburgh |
Pancreatic Cancer Resectable
|
December 13, 2017 | Phase 2 |
NCT04349228 | Abderrahmane Mami Hospital|Eshmoun Clinical Research Center|Datametrix |
COVID19|Sars-CoV2|Hydroxychloroquine|Prophylaxis|Healthcare Worker
|
April 28, 2020 | Phase 3 |
NCT04466540 | Hospital Alemão Oswaldo Cruz|EMS S+A|Hospital do Coracao|Hospital Israelita Albert Einstein|Hospital Sirio-Libanes|Hospital Moinhos de Vento|Brazilian Research In Intensive Care Network |
COVID-19
|
May 12, 2020 | Phase 4 |
NCT03592823 | First Affiliated Hospital of Harbin Medical University |
Atrial Fibrillation
|
August 1, 2018 | Phase 4 |
NCT03979651 | Hospices Civils de Lyon |
Metastatic NRAS Melanoma
|
October 15, 2019 | Not Applicable |
NCT02722369 | University College, London |
Small Cell Lung Cancer
|
March 14, 2017 | Phase 2 |
NCT02451748 | University of Illinois at Chicago|UCB Pharma |
Rheumatoid Arthritis
|
August 2015 | Phase 4 |
NCT05518110 | Cancer Trials Ireland|Novartis |
Pancreatic Cancer
|
September 15, 2022 | Phase 2 |
NCT02303405 | Charles Drew University of Medicine and Science |
Diabetes Mellitus Type 2 With Hyperglycemia
|
November 2014 | Phase 2 |
NCT00568880 | Abramson Cancer Center of the University of Pennsylvania |
Multiple Myeloma and Plasma Cell Neoplasm
|
September 8, 2010 | Phase 1 |
NCT04332991 | Massachusetts General Hospital|National Heart, Lung, and Blood Institute (NHLBI) |
Coronavirus|Acute Respiratory Infection|SARS-CoV Infection
|
April 2, 2020 | Phase 3 |
NCT04954040 | Maimónides Biomedical Research Institute of Córdoba |
Acute Respiratory Distress Syndrome|Covid19
|
February 10, 2021 | Phase 2 |
NCT04435808 | University of New Mexico |
COVID-19
|
April 14, 2020 | Phase 1|Phase 2 |
NCT04374552 | Rutgers, The State University of New Jersey |
SARS-CoV-2 Infection
|
May 5, 2020 | Phase 2 |
NCT04434144 | Upazila Health & Family Planning Officer´s (UHFPO) Office, Chakoria, Cox´s Bazar |
Ivermectin|Hydroxychloroquine|COVID19
|
May 2, 2020 | |
NCT03791827 | Xiqiang Dang|The Children´s Hospital Affiliated to Suzhou University|Shandong Provincial Hospital|Guizhou Provincial People´s Hospital|LanZhou University|The First Affiliated Hospital of Inner Mongolia Medical College|People´s Hospital of Zhangjiajie|Puyang Oilfield General Hospital|The First Affiliated Hospital of Anhui Medical University|Guizhou Maternal and Child Health Care Hospital|The Second Affiliated Hospital & Yuying Children´s Hospital of Wenzhou Medical University|Shenzhen Children´s Hospital|The Second Affiliated Hospital of Harbin Medical University|Yichang Central People´s Hospital|Xian Children´s Hospital|Wuhan Children´s Hospital, Tongji Medical College, Huazhong University of Science & Technology|The First People´s Hospital of Yunnan|The First Affiliated Hospital of Xiamen University|The First Affiliated Hospital of Xinxiang Medical College|Shanxi Provincial Maternity and Children´s Hospital|Liaocheng People´s Hospital|Fujian Provincial Hospital|First Affiliated Hospital of Guangxi Medical University|Second Hospital of Lanzhou University|Guangzhou First People´s Hospital|The Second Hospital of Shandong University|Children´s Hospital of Hebei Province|Beijing Children´s Hospital|Zhengzhou Children´s Hospital|The Children´s Hospital of Chongqing Medical University|Wuxi Children´s Hospital|The Children´s Hospital of Fudan University|Shanghai Children´s Medical Center|Qilu Children´s Hospital of Shandong University|Second Xiangya Hospital of Central South University |
Lupus Nephritis|Children|Steroid|Immunosuppressive Treatment
|
December 1, 2018 | |
NCT04322396 | Chronic Obstructive Pulmonary Disease Trial Network, Denmark |
Virus Diseases|Infection Viral|Corona Virus Infection
|
April 6, 2020 | Phase 2 |
NCT05110651 | Nicholas Carlson|Rigshospitalet, Denmark |
COVID-19|End Stage Renal Disease
|
April 10, 2020 | Phase 4 |
NCT04497519 | University Medical Center Groningen |
Covid19
|
September 15, 2020 | Phase 1 |
NCT01272310 | Sheba Medical Center |
Chronic Hepatitis C
|
January 2011 | Phase 1|Phase 2 |
NCT04261517 | Shanghai Public Health Clinical Center |
Pneumonia, Pneumocystis|Coronavirus|COVID-19
|
February 6, 2020 | Phase 3 |
NCT05237843 | Ain Shams University |
Recurrent Pregnancy Loss
|
March 1, 2022 | Phase 1 |
NCT01480154 | National Cancer Institute (NCI) |
Advanced Malignant Solid Neoplasm|Stage III Cutaneous Melanoma AJCC v7|Stage III Prostate Cancer AJCC v7|Stage III Renal Cell Cancer AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Prostate Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7
|
November 23, 2011 | Phase 1 |
NCT05026801 | Iterum Therapeutics, International Limited|Waterbury Hospital |
Respiratory Tract Infection Viral
|
February 8, 2021 | Phase 3 |
NCT04341870 | Assistance Publique - Hôpitaux de Paris |
COVID19|SARS-CoV-2 Infection
|
April 11, 2020 | Phase 2|Phase 3 |
NCT04332094 | Fundació Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau|Instituto de Salud Carlos III |
COVID-19
|
April 2, 2020 | Phase 2 |
NCT04347980 | Centre Chirurgical Marie Lannelongue |
Respiratory Distress Syndrome, Adult|COVID-19
|
April 17, 2020 | Phase 3 |
NCT04373044 | University of Southern California|National Cancer Institute (NCI) |
Symptomatic COVID-19 Infection Laboratory-Confirmed
|
May 1, 2020 | Phase 2 |
NCT04201457 | Pediatric Brain Tumor Consortium |
Low Grade Glioma (LGG) of Brain With BRAF Aberration|High Grade Glioma (HGG) of the Brain With BRAF Aberration|Low Grade Glioma of Brain With Neurofibromatosis Type 1
|
November 20, 2019 | Phase 1|Phase 2 |
NCT04321616 | Oslo University Hospital |
SARS-CoV Infection|COVID 19|Acute Respiratory Distress Syndrome ARDS
|
March 28, 2020 | Phase 2|Phase 3 |
NCT02444728 | Chinese SLE Treatment And Research Group|Peking Union Medical College Hospital |
Thrombocytopenia
|
July 2015 | Phase 3 |
NCT01537315 | University of Arkansas |
Kidney Failure, Chronic|Cardiovascular Disease|Arteriosclerosis
|
February 2012 | Phase 2 |
NCT03671174 | RenJi Hospital|The First Affiliated Hospital of Anhui Medical University|China-Japan Union Hospital, Jilin University|Wuxi No. 2 People´s Hospital|The First Affiliated Hospital with Nanjing Medical University|Xiangya Hospital of Central South University |
Undifferentiated Connective Tissue Disease|Recurrent Pregnancy Loss
|
August 2, 2019 | Not Applicable |
NCT04347512 | University Hospital, Strasbourg, France |
Sars-CoV-2, Community-Acquired Pneumonia,COVID-19
|
June 2, 2020 | Phase 3 |
NCT04460547 | Qassim University |
COVID-19
|
July 25, 2020 | |
NCT04329832 | Intermountain Health Care, Inc.|University of Utah |
COVID-19
|
March 30, 2020 | Phase 2 |
NCT04383717 | Cairo University |
Respiratory Tract Infections
|
May 5, 2020 | Phase 3 |
NCT03025087 | Duke University |
Individuals Undergoing Cardiac and General Surgery
|
June 19, 2017 | Phase 4 |
NCT04336332 | Rutgers, The State University of New Jersey |
SARS-CoV-2|COVID-19
|
April 1, 2020 | Phase 2 |
NCT04334967 | Providence Health & Services|Center for Outcomes Research and Education|Providence Cancer Center, Earle A. Chiles Research Institute |
COVID-19|Corona Virus Infection|SARS-CoV-2|2019-nCoV|2019 Novel Coronavirus
|
March 30, 2020 | Phase 4 |
NCT04382625 | Kootenai Health|Washington State University |
SARS-CoV-2 Pneumonia|COVID-19
|
October 2020 | Phase 4 |
NCT04354428 | University of Washington|Bill and Melinda Gates Foundation |
COVID-19|SARS-CoV-2
|
April 16, 2020 | Phase 2|Phase 3 |
NCT04341207 | Gustave Roussy, Cancer Campus, Grand Paris |
Cancer & COVID 19
|
April 3, 2020 | Phase 2 |
NCT04333225 | Baylor Research Institute |
COVID-19
|
April 3, 2020 | Phase 2 |
NCT04316377 | University Hospital, Akershus |
Corona Virus Infection
|
March 25, 2020 | Phase 4 |
NCT03414502 | University of Nebraska |
Rheumatoid Arthritis
|
August 2007 | Phase 3 |
NCT01573754 | The University of Texas Medical Branch, Galveston |
Porphyria Cutanea Tarda
|
March 21, 2006 | Phase 2 |
NCT04858633 | Postgraduate Institute of Medical Education and Research |
Covid19|COVID-19 Prevention
|
March 22, 2021 | Phase 3 |
NCT04351724 | Medical University of Vienna|Kaiser Franz Josef Hospital|SMZ-Ost Donauspital|Otto Wagner Hospital|Hospital Hietzing|Wilhelminenspital Vienna|Medical University Innsbruck|Medical University of Graz|Kepler University Hospital |
COVID-19
|
April 16, 2020 | Phase 2|Phase 3 |
NCT04344379 | Assistance Publique - Hôpitaux de Paris |
SARS-CoV-2 Infection
|
April 17, 2020 | Phase 3 |
NCT03400254 | Abramson Cancer Center of the University of Pennsylvania|Translational Breast Cancer Research Consortium|Pfizer|Hoosier Cancer Research Network|Breast Cancer Research Foundation |
Breast Cancer
|
February 26, 2019 | Phase 1|Phase 2 |
NCT04377646 | Military Hospital of Tunis|UR17DN02 : Autoimmune Diseases Research Unit|Dacima Consulting |
Sars-CoV2|COVID19
|
May 4, 2020 | Phase 3 |
NCT01006369 | Rutgers, The State University of New Jersey|National Cancer Institute (NCI) |
Colorectal Cancer
|
May 2009 | Phase 2 |
NCT03540810 | University Hospital, Angers |
Primary Antiphospholipid Syndrome
|
August 15, 2018 | Phase 3 |
NCT04981145 | Second Affiliated Hospital, School of Medicine, Zhejiang University |
Primary Sjögren´s Syndrome
|
January 14, 2022 | Phase 4 |
NCT04735068 | Abramson Cancer Center of the University of Pennsylvania|Pfizer |
Non-Small Cell Lung Cancer|KRAS Mutation-Related Tumors
|
April 9, 2021 | Phase 2 |
NCT04346667 | Government of Punjab, Specialized Healthcare and Medical Education Department|Mayo Hospital Lahore|Services Institute of Medical Sciences, Pakistan|Pakistan Kidney and Liver Institute|Forman Christian College, Pakistan|Harvard School of Public Health (HSPH) |
SARS-CoV-2|Coronavirus Infection|Asymptomatic Condition|COVID-19
|
April 14, 2020 | Phase 4 |
NCT04214418 | Columbia University|Genentech, Inc. |
Gastrointestinal Cancer
|
February 12, 2020 | Phase 1|Phase 2 |
NCT04355026 | General and Teaching Hospital Celje |
Covid-19
|
April 10, 2020 | Phase 4 |
NCT04532346 | Children´s Hospital of Fudan University |
Interstitial Lung Disease|Surfactant Dysfunction
|
August 2022 | Early Phase 1 |
NCT04429867 | WellStar Health System |
COVID-19
|
May 7, 2020 | Phase 4 |
NCT04522466 | Centre Hospitalier Universitaire de Saint Etienne|CHU Saint-Etienne - Laboratoire de Pharmacologie - Toxicologie - Gaz du sang |
Sars-CoV2
|
April 3, 2020 | Phase 3 |
NCT04443725 | Cairo University |
COVID-19
|
July 2020 | Phase 2|Phase 3 |
NCT04421664 | McGill University Health Centre+Research Institute of the McGill University Health Centre|University of Manitoba|University of Alberta|University of British Columbia|McMaster University|Lawson Health Research Institute|Eastern Health|University of Minnesota |
Corona Virus Infection|SARS-CoV Infection|Coronavirus
|
March 25, 2020 | Phase 3 |
NCT02756546 | Cairo University |
Systemic Lupus Erythematosis
|
September 2014 | Phase 1|Phase 2 |
NCT03377179 | RedHill Biopharma Limited |
Cholangiocarcinoma|Cholangiocarcinoma Non-resectable|Cholangiocarcinoma, Perihilar|Cholangiocarcinoma, Extrahepatic|Cholangiocarcinoma, Intrahepatic
|
March 7, 2018 | Phase 2 |
NCT04352946 | GeoSentinel Foundation |
Prophylaxis|COVID-19|Health Care Worker|Hydroxychloroquine
|
April 24, 2020 | Phase 3 |
NCT04873895 | Abramson Cancer Center of the University of Pennsylvania|Pfizer |
Colorectal Neoplasms Malignant
|
January 24, 2022 | Phase 1 |
NCT04359953 | University Hospital, Strasbourg, France |
COVID-19 Infection
|
April 25, 2020 | Phase 3 |
NCT03813771 | University of Leeds|Samsung Bioepis Co., Ltd. |
Rheumatoid Arthritis
|
March 2019 | Phase 4 |
NCT04394182 | Fundacion GenesisCare|Hospital La Milagrosa|Hospital Vithas Valencia Consuelo |
Pneumonia, Viral|Cytokine Storm
|
April 21, 2020 | Not Applicable |
NCT00946790 | Sandoz |
Immunosuppression|Rheumatism
|
July 1993 | Phase 1 |
NCT04351620 | University of Chicago |
COVID-19
|
April 2020 | Phase 1 |
NCT02433184 | University of Leeds |
Rheumatoid Arthritis
|
July 2011 | Phase 4 |
NCT02735707 | UMC Utrecht|Australian and New Zealand Intensive Care Research Centre|Medical Research Institute of New Zealand|Unity Health|Berry Consultants|Global Coalition for Adaptive Research|University of Pittsburgh Medical Center|Intensive Care National Audit & Research Centre|St. Marianna University School of Medicine|National Intensive Care Surveillance MORU |
Community-acquired Pneumonia, Influenza, COVID-19
|
April 11, 2016 | Phase 3 |
NCT04860284 | Makerere University |
Covid19
|
September 18, 2020 | Phase 2 |
NCT01417403 | Virginia Commonwealth University|National Cancer Institute (NCI) |
Bone Metastases|Unspecified Adult Solid Tumor, Protocol Specific
|
August 2011 | Phase 1 |
NCT04414241 | Universidad Peruana Cayetano Heredia |
SARS-CoV-2
|
June 25, 2020 | Phase 3 |
NCT04368351 | University of Roma La Sapienza |
COVID|Pneumonia|Diarrhea
|
March 1, 2020 | |
NCT00771056 | Northwell Health |
B-Cell Chronic Lymphocytic Leukemia
|
July 2008 | Phase 2 |
NCT00259610 | University of Alabama at Birmingham|Amgen|Barr Laboratories|Pfizer |
Rheumatoid Arthritis
|
May 2004 | Phase 4 |
NCT03754179 | Universitair Ziekenhuis Brussel|University Hospital, Ghent |
Melanoma
|
January 23, 2018 | Phase 1|Phase 2 |
NCT04385264 | Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland |
COVID-19
|
January 2022 | Phase 2|Phase 3 |
NCT04362332 | UMC Utrecht|ZonMw: The Netherlands Organisation for Health Research and Development |
COVID-19
|
April 14, 2020 | Phase 4 |
NCT04353271 | University of South Alabama |
Covid 19|Corona Virus Infection
|
April 17, 2020 | Phase 2|Phase 3 |
NCT02124681 | University of Pittsburgh |
Insulin Resistance
|
April 2014 | Phase 1 |
NCT02200146 | University of Milano Bicocca|Agenzia Italiana del Farmaco |
Pulmonary Sarcoidosis
|
March 2009 | Phase 3 |
NCT04346329 | Universidad Nacional de Colombia|Fundación Salud de los Andes |
COVID
|
March 30, 2020 | Phase 3 |
NCT04590274 | International Brain Research Foundation |
Covid19|SARS (Severe Acute Respiratory Syndrome)
|
November 2020 | Phase 1 |
NCT04395768 | National Institute of Integrative Medicine, Australia |
COVID19
|
September 9, 2020 | Phase 2 |
NCT04446104 | National University Hospital, Singapore |
Covid-19
|
May 13, 2020 | Phase 3 |
NCT04354441 | Sir Mortimer B. Davis - Jewish General Hospital |
COVID-19|SARS-CoV-2|Pregnant Women|Hydroxychloroquine
|
May 2020 | Phase 2 |
NCT04077957 | Nanfang Hospital of Southern Medical University |
Ankylosing Spondylitis|Spondyloarthritis
|
October 7, 2019 | Phase 4 |
NCT00909831 | Abramson Cancer Center of the University of Pennsylvania|National Cancer Institute (NCI) |
Unspecified Adult Solid Tumor, Protocol Specific
|
October 2008 | Phase 1 |
NCT02615938 | Matthias Griese|Ludwig-Maximilians - University of Munich |
Interstitial Lung Disease|Diffuse Parenchymal Lung Disease|Children´s Interstitial Lung Disease
|
April 2015 | Phase 2 |
NCT04336748 | Medical University of Vienna |
Sars-CoV2|Infection Viral|Healthcare Worker|Prophylaxis
|
April 2020 | Phase 3 |
NCT04153201 | National and Kapodistrian University of Athens |
Antiphospholipid Syndrome
|
January 15, 2013 | Not Applicable |
NCT04981379 | Health Institutes of Turkey |
Covid19
|
November 16, 2020 | Phase 3 |
NCT04386057 | Kimberly Perez|Eli Lilly and Company|Dana-Farber Cancer Institute |
Pancreatic Cancer|Advanced Cancer
|
May 27, 2020 | Phase 2 |
NCT04328467 | University of Minnesota |
COVID-19|Corona Virus Infection|ARDS|Acute Respiratory Distress Syndrome
|
April 6, 2020 | Phase 3 |
NCT04391127 | Centenario Hospital Miguel Hidalgo |
COVID-19
|
May 4, 2020 | Phase 3 |
NCT04755322 | Assiut University |
Hydroxychloroquine
|
March 1, 2021 | Not Applicable |
NCT04363827 | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori|University of Bologna |
COVID19|Hydroxychloroquine|Prophylaxis|Treatment|SARS-CoV-2
|
May 14, 2020 | Phase 2 |
NCT04345653 | Hackensack Meridian Health |
Covid19
|
April 14, 2020 | Phase 2 |
NCT00728845 | University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey |
Lung Cancer
|
June 16, 2008 | Phase 1|Phase 2 |
NCT02316340 | The University of Texas Health Science Center at San Antonio |
Colorectal Cancer
|
February 11, 2015 | Phase 2 |
NCT00632866 | Assistance Publique - Hôpitaux de Paris|Sanofi |
Primary Sjögren´s Syndrome
|
March 2008 | Phase 3 |
NCT00962845 | Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey |
Melanoma (Skin)
|
September 2010 | Early Phase 1 |
NCT01833845 | BioLineRx, Ltd. |
Hepatitis C
|
April 2013 | Phase 1|Phase 2 |
NCT01273805 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Massachusetts General Hospital |
Pancreatic Cancer
|
January 2011 | Phase 2 |
NCT01207739 | Radboud University Medical Center|Sint Maartenskliniek|ZonMw: The Netherlands Organisation for Health Research and Development |
Lyme Disease|Borrelia Infection
|
September 2010 | Phase 4 |
NCT03856866 | The Hospital for Sick Children |
Zellweger Syndrome|Peroxisome Biogenesis Disorders
|
January 11, 2019 | Phase 2 |
NCT04318015 | National Institute of Respiratory Diseases, Mexico |
COVID-19|Severe Acute Respiratory Syndrome
|
April 14, 2020 | Phase 3 |
NCT04316494 | Guy´s and St Thomas´ NHS Foundation Trust|Medical Research Council |
ANCA Associated Vasculitis|Microscopic Polyangiitis|Churg-Strauss Syndrome|Wegener Granulomatosis
|
December 17, 2020 | Phase 4 |
NCT00413361 | Assistance Publique - Hôpitaux de Paris|Sanofi-Synthelabo |
Systemic Lupus Erythematosus
|
June 2007 | Phase 4 |
NCT05626348 | Qilu Hospital of Shandong University |
Arthritis, Rheumatoid
|
December 22, 2021 | Phase 4 |
NCT04566133 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Bile Duct Cancer|Biliary Cancer|Biliary Tract Neoplasms|Cholangiocarcinoma
|
February 15, 2022 | Phase 2 |
NCT04318444 | Columbia University |
COVID-19|Corona Virus Infection
|
March 29, 2020 | Phase 2|Phase 3 |
NCT02714634 | University Hospital, Strasbourg, France |
Rheumatoid Arthritis|Insufficient Response to Methotrexate or Leflunomide
|
March 30, 2016 | Phase 4 |
NCT04361318 | Tanta University |
COVID-19
|
May 2020 | Phase 2|Phase 3 |
NCT01206530 | Abramson Cancer Center of the University of Pennsylvania |
Rectal Cancer|Colon Cancer|Metastasis|Adenocarcinoma
|
September 2010 | Phase 1|Phase 2 |
NCT04458948 | University of New Mexico |
COVID-19
|
March 24, 2020 | Phase 2 |
NCT03019926 | University Hospital Center of Martinique |
Systemic Lupus, Skin Lupus
|
January 19, 2017 | |
NCT01227135 | Lynn McMahon|Medical Research Council|CRUK Trials unit Glasgow|University of Glasgow |
Leukemia
|
March 2010 | Phase 2 |
NCT04341441 | Henry Ford Health System |
COVID-19|Coronavirus|Coronavirus Infections|SARS-CoV 2
|
April 7, 2020 | Phase 3 |
NCT03215264 | Abramson Cancer Center of the University of Pennsylvania |
Colorectal Cancer
|
October 2, 2017 | Phase 1|Phase 2 |
NCT04437693 | Hamad Medical Corporation |
COVID 19
|
August 31, 2020 | Phase 2|Phase 3 |
NCT01897116 | Abramson Cancer Center of the University of Pennsylvania |
Melanoma
|
June 2013 | Phase 1 |
NCT02930343 | Jawaharlal Institute of Postgraduate Medical Education & Research |
Rheumatoid Arthritis
|
September 2016 | Phase 3 |
NCT04322123 | Hospital do Coracao|Hospital Israelita Albert Einstein|Hospital Sirio-Libanes|Brazilian Research In Intensive Care Network|EMS |
Coronavirus Infections
|
April 1, 2020 | Phase 3 |
NCT04303507 | University of Oxford |
COVID19|Coronavirus|Acute Respiratory Illnesses
|
April 29, 2020 | Not Applicable |
NCT00031824 | Children´s Oncology Group|National Cancer Institute (NCI) |
Graft Versus Host Disease
|
April 2002 | Phase 3 |
NCT04403100 | Cardresearch|Cardresearch - Cardiologia Assistencial e de Pesquisa LTDA|Cytel Inc. |
COVID-19|Coronavirus Infection|Virus Disease|Acute Respiratory Infection|SARS-CoV Infection
|
June 3, 2020 | Phase 3 |
NCT04349592 | Hamad Medical Corporation |
Covid19
|
April 14, 2020 | Not Applicable |
NCT04369742 | NYU Langone Health|State University of New York - Downstate Medical Center |
COVID-19
|
April 15, 2020 | Phase 2 |
NCT04370015 | Services Institute of Medical Sciences, Pakistan |
SARS-CoV-2|Healthcare Workers
|
May 15, 2020 | Not Applicable |
NCT04575558 | Latin American Cooperative Oncology Group|Oncoclínicas |
Sars-CoV2
|
June 30, 2020 | Phase 2 |
NCT01396200 | Abramson Cancer Center of the University of Pennsylvania |
Myeloma
|
June 2011 | Early Phase 1 |
NCT01550367 | Leonard Appleman|Prometheus Laboratories|University of Pittsburgh |
Metastatic Renal Cell Carcinoma
|
March 2012 | Phase 1|Phase 2 |
NCT04359537 | Shaheed Zulfiqar Ali Bhutto Medical University |
COVID 19
|
May 1, 2020 | Phase 2 |
NCT02603146 | National Institute of Allergy and Infectious Diseases (NIAID)|Autoimmunity Centers of Excellence |
Healthy Participants|Rheumatoid Arthritis (RA) Prevention
|
April 27, 2016 | Phase 2 |
NCT02421575 | Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey |
Prostate Carcinoma
|
July 2012 | Early Phase 1 |
NCT04005768 | Universitaire Ziekenhuizen KU Leuven |
Obesity
|
August 1, 2019 | Phase 4 |
NCT01026844 | Massachusetts General Hospital|Genentech, Inc. |
Non-small Cell Lung Cancer
|
July 2007 | Phase 1 |
NCT03037437 | The University of Texas Health Science Center at San Antonio |
Hepatocellular Cancer
|
February 16, 2017 | Phase 2 |
NCT04161339 | Instituto de Cardiologia do Rio Grande do Sul|Hospital de Clinicas de Porto Alegre |
Cardiovascular Diseases|Endothelial Dysfunction|Sleep Apnea|Atherosclerosis|Coronary Artery Disease
|
July 1, 2019 | Phase 4 |
NCT04371926 | Texas Cardiac Arrhythmia Research Foundation |
COVID-19
|
June 2020 | Not Applicable |
NCT01495403 | Mayo Clinic |
Liver Cirrhosis|Muscle Cramps
|
December 2011 | Early Phase 1 |
NCT03428945 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Juvenile Diabetes Research Foundation |
Type1 Diabetes Mellitus
|
August 15, 2018 | Phase 2 |
NCT04315948 | Institut National de la Santé Et de la Recherche Médicale, France |
Corona Virus Infection
|
March 22, 2020 | Phase 3 |
NCT04340544 | University Hospital Tuebingen|Robert Bosch Medical Center|Universitätsklinikum Hamburg-Eppendorf|Bernhard Nocht Institute for Tropical Medicine |
COVID-19
|
April 22, 2020 | Phase 2 |
NCT04477083 | Mansoura University |
Covid19|Hydroxychloroquine Adverse Reaction
|
July 15, 2020 | Not Applicable |
NCT05287321 | Yoo-min Kim|Ministry of Health & Welfare, Korea|Chung-Ang University Hosptial, Chung-Ang University College of Medicine |
Preeclampsia
|
April 15, 2022 | Phase 3 |
NCT03015324 | Peng Wang, MD PhD|University of Kentucky |
Solid Tumor
|
August 8, 2017 | Phase 1 |
NCT04714515 | University of Sargodha|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|Shaukat Khanum Memorial Cancer Hospital & Research Centre|Shanghai Jiao Tong University School of Medicine|Teesside University |
Covid19|SARS-CoV-2 Infection
|
February 20, 2020 | |
NCT04335552 | Duke University |
SARS-CoV-2
|
April 17, 2020 | Phase 2 |
NCT04308668 | University of Minnesota|McGill University Health Centre+Research Institute of the McGill University Health Centre|University of Manitoba|University of Alberta |
Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection|Coronavirus|Coronavirus Infections
|
March 17, 2020 | Phase 3 |
NCT04350671 | Shahid Beheshti University of Medical Sciences |
COVID-19
|
April 15, 2020 | Phase 4 |
NCT03305263 | Rigshospitalet, Denmark |
Recurrent Pregnancy Loss
|
January 25, 2018 | Phase 3 |
NCT04390061 | Università Politecnica delle Marche|Azienda Ospedaliera Ospedali Riuniti Marche Nord|Ospedale Civile Santo Spirito, Pescara|Università Magna Grecia, Catanzaro|ASST Papa Giovanni XXIII, Bergamo|Azienda Ospedaliero Universitaria Policlinico Umberto I, Roma|ASST Cremona, Cremona|Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano|Ospedale di Circolo e Fondazione Macchi, Varese |
Pneumonitis, Interstitial|COVID-19
|
June 2020 | Phase 2 |
NCT04228263 | Assiut University |
Hydroxychloroquine
|
January 1, 2020 | Not Applicable |
NCT02913157 | University of Calgary |
Multiple Sclerosis, Primary Progressive
|
November 2016 | Phase 2 |
NCT04746365 | Elaraby Hospital|Shebin El-Kom Teaching Hospital |
Covid19
|
December 6, 2020 | Phase 4 |
NCT01634893 | The University of Texas Health Science Center at San Antonio |
Refractory or Relapsed Solid Tumors
|
June 2012 | Phase 1 |
NCT04371406 | Assistance Publique - Hôpitaux de Paris |
Covid-19
|
April 2020 | Phase 3 |
NCT02595346 | University Hospital, Rouen |
Antiphospholipid Syndrome (APS)
|
June 2016 | Phase 2 |
NCT01494155 | Massachusetts General Hospital |
Pancreatic Cancer
|
December 2011 | Phase 2 |
NCT00977470 | Massachusetts General Hospital|Stanford University|Yale University|University of Maryland, College Park|Genentech, Inc. |
Non-small Cell Lung Cancer
|
October 2009 | Phase 2 |
NCT02910076 | Hadassah Medical Organization |
Diabetes Type Two
|
October 2016 | Phase 1|Phase 2 |
NCT04354649 | AHS Cancer Control Alberta |
Arthritis|Arthralgia
|
July 29, 2021 | Phase 2 |
NCT04307693 | Asan Medical Center |
COVID-19
|
March 11, 2020 | Phase 2 |
NCT00102557 | National Institute of Dental and Craniofacial Research (NIDCR)|National Institutes of Health Clinical Center (CC) |
Lichen Planus, Oral
|
January 2005 | Phase 2 |
NCT03513211 | St Vincent´s Hospital, Sydney |
Prostate Cancer
|
August 23, 2018 | Phase 1|Phase 2 |
NCT04347031 | Burnasyan Federal Medical Biophysical Center |
Pneumonia, Viral|Respiratory Failure
|
April 8, 2020 | Phase 2|Phase 3 |
NCT04350281 | The University of Hong Kong |
COVID
|
April 9, 2020 | Phase 2 |
NCT02631252 | Alison Sehgal, MD, MS|University of Pittsburgh |
Leukemia, Acute Myelogenous
|
August 18, 2016 | Phase 1 |
NCT04569890 | RenJi Hospital |
Rheumatoid Arthritis|Pregnancy Related
|
December 1, 2020 | Not Applicable |
NCT04338906 | Heinrich-Heine University, Duesseldorf|Universitätsklinikum Hamburg-Eppendorf|University Hospital Frankfurt|St. Georg Hospital Leipzig, Germany|Hospital Schwabing Munich, Germany|Missioklinik, Wuerzburg, Germany |
COVID
|
May 2020 | Phase 4 |
NCT04387760 | Royal College of Surgeons in Ireland - Medical University of Bahrain|Ebrahim Khalil Kanoo Community Medical Center|Hereditary blood Disorder Centre - Salmaniya Medical Complex|Mohammed Bin Khalifa Bin Sulman Al Khalifa Cardiac Centre, Awali|Jidhafs COVID-19 Centre|Sitra FICU|Salmaniya Medical Complex- 6th Floor|Salmaniya Medical Complex- Helipad |
SARS-CoV 2|COVID-19
|
August 11, 2020 | Phase 2 |
NCT03032406 | Abramson Cancer Center of the University of Pennsylvania |
Breast Cancer Stage IIB
|
January 23, 2017 | Phase 2 |
NCT04321278 | Hospital Israelita Albert Einstein|EMS|Hospital do Coracao|Hospital Sirio-Libanes|Brazilian Research In Intensive Care Network |
Coronavirus Infections|Pneumonia, Viral
|
March 28, 2020 | Phase 3 |
NCT01842594 | Shin Kong Wu Ho-Su Memorial Hospital |
Sarcoma
|
August 2012 | Phase 2 |
NCT03275870 | Elena Gonzalez Brant, MD|University of Pittsburgh |
Hidradenitis Suppurativa|Hidradenitis|Acne Inversa|Boils|Follicular Occlusion Triad|Follicular Occlusion Tetrad
|
September 28, 2017 | Phase 1|Phase 2 |
NCT04573153 | ScandiBio Therapeutics AB|Istanbul Medipol University Hospital|Istanbul Umraniye Training and Research Hospital|Bakirkoy Dr. Sadi Konuk Research and Training Hospital|Dr. Lutfi Kirdar Kartal Training and Research Hospital|Bagcilar Training and Research Hospital|Kanuni Sultan Suleyman Training and Research Hospital|Alanya Alaaddin Keykubat University Alanya Training and Research Hospital|Canakkale 18 Mart University Health Research and Application Hospital|Monitor CRO |
COVID-19
|
September 21, 2020 | Phase 2|Phase 3 |
NCT04329923 | Ravi Amaravadi, MD|University of Pennsylvania |
COVID-19
|
April 9, 2020 | Phase 2 |
NCT04973566 | Janssen Research & Development, LLC |
Healthy
|
August 31, 2021 | Phase 1 |
NCT00873496 | Ege University |
Sjögren´s Syndrome|Xerostomia
|
January 2005 | |
NCT04350684 | Shahid Beheshti University of Medical Sciences |
COVID-19
|
April 15, 2020 | Phase 4 |
NCT04779047 | October 6 University|Beni-Suef University |
Covid19|Pneumonia
|
October 1, 2020 | Phase 4 |
NCT04345861 | University Hospital, Montpellier |
Coronavirus Infection|Pneumonia, Viral
|
April 11, 2020 | Phase 2|Phase 3 |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
1M HCl : 100 mg/mL ( 297.73 mM ; adjust pH to 2 with HCl)
H 2 O : 1.67 mg/mL ( 4.97 mM ; ultrasonic and warming and heat to 60°C)
DMSO : < 1 mg/mL (insoluble or slightly soluble)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.9773 mL | 14.8867 mL | 29.7734 mL |
5 mM | 0.5955 mL | 2.9773 mL | 5.9547 mL |
10 mM | 0.2977 mL | 1.4887 mL | 2.9773 mL |
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.